Table 1 Clinical characteristics of the study population
Clinical characteristics (whole cohort) | ||||||
|---|---|---|---|---|---|---|
| Â | Healthy volunteers | Patients affected with atherosclerosis | ||||
Male (n = 14) | Female (n = 16) | Overall (n = 30) | Male (n = 17) | Female (n = 13) | Overall (n = 30) | |
Mean age (years) | 30.31 (± 7.21) | 33.29 (± 8.46) | 31.51 (± 7.90) | 62.92 (± 11.08) | 69.6 (± 9.41) | 65.81 (± 8.01) |
Mean height (cm) | 183.57 (± 6.44) | 167.83 (± 6.29) | 175.16 ± (6.37) | 174.83 (± 6.71) | 163.29 (± 4.99) | 169,82 (± 6,62) |
Mean weight (kg) | 84.78 (± 8.51) | 66.14 (± 3.99) | 74.84 (± 6.84) | 80.71 (± 6.89) | 62.19 (± 5.71) | 72.68 (± 6.33) |
BMI | 23.22 (± 4.10) | 23.19 (± 3.01) | 23.21 (± 3.63) | 26.03 (± 2.81) | 23.82 (± 2.91) | 25.07 (± 2.89) |
Hip-to-waist ratio | 0.91 (± 0.08) | 0.83 (± 0.05) | 0.87 (± 0.07) | 0.99 (± 0.13) | 0.84 (± 0.06) | 0.93 (± 0.09) |
Number of subjects with a history of smoking (n, %) | 2 | 3 | 5 | 12 (71%) | 10 (77%) | 22 (73%) |
Patients affected with atherosclerosis | Â | Â | Â |
|---|---|---|---|
Type of CAD | Â | Â | Â |
st.p. Major adverse cardiovascular event (n, %) | 12 (71%) | 6 (46%) | 18 (60%) |
Chronic coronary syndrome (n, %) | 5 (29%) | 7 (54%) | 13 (43%) |
Mean years since first diagnosis | 5.71 (± 4.33) | 3.47 (± 3.07) | 4.73 (± 3.62) |
Number of subjects… | |||
Treated with antiplatelet therapy (n, %) | 13 (76%) | 6 (46%) | 19 (63%) |
Of which treated with dual antiplatelet therapy (n, %) | 4 (24%) | 2 (15%) | 6 (20%) |
With coronary stents (n, %) | 15 (88%) | 9 (69%) | 24 (80%) |
After coronary bypass surgery (n, %) | 6 (45%) | 3 (23%) | 9 (30%) |
With arterial hypertension (n, %) | 15 (88%) | 10 (76%) | 25 (83%) |
With diabetes mellitus (n, %) | 8 (47%) | 4 (30%) | 12 (40%) |
With metabolic syndrome (n, %) | 8 (47%) | 3 (23%) | 11 (37%) |